Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Face Serum

$51.00

The product description should talk about the product in a truthful yet flattering way. Remember to include information that the potential buyer would need, for example, details on sizing, color, and function.

Volume: 50ml

NISM XV Cohort

Market Education

Equity Basic

Equity Pro

Elite Services

Services

Terms

Support

Customer Care: +91709252879

Timing: Mon-Fri (10am - 6pm)

Office Address: No. 11/6, Alwarpet 1st Street, CHENNAI, TAMIL NADU, 600018

SEBI Registered Research Analyst — INH000026725.

Policies

PMLA (AML) Policy

Terms and Conditions

Building Wealth Through Market Intelligence.

SEBI Registered Research Analyst Details
Registered Name: B KARTHIKEYAN | Type of Registration: Individual | Reg. No: INH000026725 | Validity: May 05, 2026 — Perpetual

Registered Address: No. 11/6, Alwarpet 1st Street, CHENNAI, TAMIL NADU, 600018 · Tel: +91 9840591735 · Email: karthikeyanbalu2002@gmail.com

Grievance Officer: B KARTHIKEYAN · karthikeyanbalu2002@gmail.com · +91 9840591735

SEBI Office:SEBI Bhavan BKC, Plot No. C4-A, ‘G’ Block, Bandra-Kurla Complex, Bandra (East), Mumbai — 400051, Maharashtra

SEBI Local Office: Overseas Towers, 7th Floor, 756-L, Anna Salai, Chennai - 600002, Tamil Nadu · Board: +91-44-28880222 · Email: sebisro@sebi.gov.in

Tel: +91-22-26449000 / 40459000 · Fax: +91-22-26449019-22 / 40459019-22 · Email: sebi@sebi.gov.in · Toll Free Investor Helpline: 1800 22 7575

SEBI SCORES(opens in new tab) · SMARTODR(opens in new tab) · NISM Certificate(opens in new tab) · SEBI SCORES — Google Play(opens in new tab) · SEBI SCORES — App Store

Disclaimer: “Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. The securities quoted on the page above are for illustration only and are not recommendatory.”